900186-73-4 Usage
Uses
Used in Pharmaceutical Industry:
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate is used as a pharmaceutical intermediate for the synthesis of various drugs and active pharmaceutical ingredients. Its diverse functional groups and unique structural characteristics make it a promising candidate for the development of new therapeutic agents.
Used in Chemical Synthesis:
In the chemical synthesis industry, (2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate serves as a key building block for the creation of complex organic compounds. Its multiple functional groups allow for various chemical reactions, enabling the synthesis of a wide range of products.
Used in Research and Development:
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate is utilized in research and development settings to study its properties, reactivity, and potential applications. Its unique structure and functional groups provide opportunities for exploring new chemical reactions and discovering novel compounds with specific properties.
Used in Material Science:
In the field of material science, (2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate may be employed as a component in the development of new materials with specific properties. Its diverse functional groups and structural characteristics could contribute to the creation of materials with unique characteristics, such as improved stability, reactivity, or selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 900186-73-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,0,1,8 and 6 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 900186-73:
(8*9)+(7*0)+(6*0)+(5*1)+(4*8)+(3*6)+(2*7)+(1*3)=144
144 % 10 = 4
So 900186-73-4 is a valid CAS Registry Number.
900186-73-4Relevant academic research and scientific papers
Thrombin Receptor Antagonists Based On The Modified Tricyclic Unit Of Himbacine
-
Page/Page column 30, (2008/06/13)
Multiple stereoisomers of the heterocyclic-substituted tricyclics of the formula: or a pharmaceutically acceptable salt, solvate, or ester of said compound wherein R and the stereochemistry are illustrated in the structural formulas herein are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds. Combination therapy with other cardiovascular agents is also claimed.
EXO- AND DIASTEREO- SELECTIVE SYNTHESES OF HIMBACINE ANALOGS
-
Page/Page column 39-40, (2008/06/13)
The application discloses a novel process for the preparation of himbacine analogs useful as thrombin receptor antagonists. The process is based in part on the use of a base-promoted dynamic epimerization of a chiral nitro center. The chemistry taught her
